Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.25 | 11.65 |
| PEG Ratio (TTM) | 0.02 | 9.91 |
| P/S Ratio (TTM) | 0.18 | 2.50 |
| P/B Ratio (TTM) | 0.72 | 5.61 |
| P/FCF Ratio (TTM) | -4.22 | 18.20 |
| Price to 5YR AVG Earnings Ratio | -7.76 | 24.68 |
| Price to 5YR AVG FCF Ratio | 9.98 | 20.09 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.58% | 7.26% |
| ROE (TTM) | -19.80% | 24.12% |
| Net Profit Margin (TTM) | -5.64% | 10.83% |
| ROIC 5YR AVG | -2.05% | -28.69% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -155.91% | -64.81% | 13.61% |
| Revenue | -5.08% | 4.70% | 3.46% |
| Net Income | -154.34% | -64.52% | 14.06% |
| Cash Flow | -63.25% | 4,911.32% | 2,970.93% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.05 | 1.94 |
| Quick Ratio (TTM) | 0.82 | 1.47 |
| D/E Ratio (TTM) | 0.52 | 1.93 |
| Interest Coverage (TTM) | -5.88 | 13.44 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.46 | 4.44 |
| LTL to 5YR AVG FCF | 0.04 | 1.48 |
| Shares Outstanding Growth 5YR AVG | N/A | 3.86% |